Department of Pathology, New York University School of Medicine, New York, NY 10016, USA.
Nucleic Acids Res. 2010 May;38(9):2944-54. doi: 10.1093/nar/gkp1252. Epub 2010 Feb 4.
V(D)J recombination entails double-stranded DNA cleavage at the antigen receptor loci by the RAG1/2 proteins, which recognize conserved recombination signal sequences (RSSs) adjoining variable (V), diversity (D) and joining (J) gene segments. After cleavage, RAG1/2 remain associated with the coding and signal ends (SE) in a post-cleavage complex (PCC), which is critical for their proper joining by classical non-homologous end joining (NHEJ). Certain mutations in RAG1/2 destabilize the PCC, allowing DNA ends to access inappropriate repair pathways such as alternative NHEJ, an error-prone pathway implicated in chromosomal translocations. The PCC is thus thought to discourage aberrant rearrangements by controlling repair pathway choice. Since interactions between RAG1/2 and the RSS heptamer element are especially important in forming the RAG-SE complex, we hypothesized that non-consensus heptamer sequences might affect PCC stability. We find that certain non-consensus heptamers, including a cryptic heptamer implicated in oncogenic chromosomal rearrangements, destabilize the PCC, allowing coding and SEs to be repaired by non-standard pathways, including alternative NHEJ. These data suggest that some non-consensus RSS, frequently present at chromosomal translocations in lymphoid neoplasms, may promote genomic instability by a novel mechanism, disabling the PCC's ability to restrict repair pathway choice.
V(D)J 重组需要 RAG1/2 蛋白在抗原受体基因座上进行双链 DNA 切割,该蛋白识别邻近可变 (V)、多样性 (D) 和连接 (J) 基因片段的保守重组信号序列 (RSS)。切割后,RAG1/2 仍然与编码和信号末端 (SE) 相关联,形成切割后复合物 (PCC),这对于它们通过经典非同源末端连接 (NHEJ) 进行正确连接至关重要。RAG1/2 中的某些突变会破坏 PCC,允许 DNA 末端进入不适当的修复途径,如替代性 NHEJ,这种易错途径与染色体易位有关。因此,PCC 被认为通过控制修复途径选择来阻止异常重排。由于 RAG1/2 与 RSS 七聚体元件之间的相互作用对于形成 RAG-SE 复合物特别重要,我们假设非共识七聚体序列可能会影响 PCC 的稳定性。我们发现某些非共识七聚体,包括与致癌性染色体重排有关的隐匿七聚体,会破坏 PCC,从而允许编码和 SE 通过非标准途径进行修复,包括替代性 NHEJ。这些数据表明,一些非共识 RSS,经常出现在淋巴肿瘤的染色体易位中,可能通过一种新的机制促进基因组不稳定性,从而使 PCC 无法限制修复途径选择。